Evidence map›Paper›PMID 27413577›Full record

ArticleStroke research and treatment2016

Influence of Medication on Fatigue Six Months after Stroke.

Amélie Ponchel, Julien Labreuche, Stéphanie Bombois, Christine Delmaire, Régis Bordet, Hilde Hénon

Registry-linked trialAbstract read
In one paragraph

Article in Stroke research and treatment, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01330160 (Characterization of Clinical, Biological, Morphological and Pharmacological Factors Influencing Occurrence of Dementia or Cognitive Disorders After Stroke), which is not on this map. Cited by 11 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01330160 completednot on this map

Characterization of Clinical, Biological, Morphological and Pharmacological Factors Influencing Occurrence of Dementia or Cognitive Disorders After Stroke

TypeobservationalSponsorUniversity Hospital, LilleRan2010 to 2021Enrolled229ConditionsCerebrovascular Disorders, Dementia
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Neuroimaging correlates of post-stroke fatigue: A systematic review and meta-analysis.International journal of stroke : official journal of the International Stroke Society · 2023
    Pooled it
  3. Related risk factors associated with post-stroke fatigue: a systematic review and meta-analysis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2021
    Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Amélie PonchelDegenerative & Vascular Cognitive Disorders, Univ. Lille, INSERM U1171, 59000 Lille, France; Department of Medical Pharmacology, Univ. Lille, 59000 Lille, France; Department of Neurology, Lille University Hospital, 59000 Lille, France.ORCID 0000-0001-5324-6600
Julien LabreucheDepartment of Statistics, EA 2694, Univ. Lille, 59000 Lille, France.
Stéphanie BomboisDegenerative & Vascular Cognitive Disorders, Univ. Lille, INSERM U1171, 59000 Lille, France; Department of Neurology, Lille University Hospital, 59000 Lille, France.
Christine DelmaireDegenerative & Vascular Cognitive Disorders, Univ. Lille, INSERM U1171, 59000 Lille, France; Department of Neuroradiology, Lille University Hospital, 59000 Lille, France.
Régis BordetDegenerative & Vascular Cognitive Disorders, Univ. Lille, INSERM U1171, 59000 Lille, France; Department of Medical Pharmacology, Univ. Lille, 59000 Lille, France.
Hilde HénonDegenerative & Vascular Cognitive Disorders, Univ. Lille, INSERM U1171, 59000 Lille, France; Department of Neurology, Lille University Hospital, 59000 Lille, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Poststroke fatigue (PSF) is frequent and affects patients' quality of life. Medication use was hypothesized as being responsible for PSF. Our objective was to evaluate potential relationships between 6-month PSF and medication use at discharge and 6 months after an ischemic stroke. This study is part of STROKDEM, an ongoing longitudinal cohort study, whose main aim is to determine predictors of poststroke dementia. Patients were included within 72 hours after an ischemic stroke and followed up with standardized evaluations. Medication use 7 days and 6 months after stroke was rated, and polypharmacy was defined as the number of categories of treatments received by a patient. PSF was evaluated using the Chalder Fatigue Scale. Medical history, vascular risk factors, depression, anxiety, and sleep disturbances were evaluated. One hundred and fifty-three patients were included: 52.9% presented PSF. PSF at 6 months was not predicted by medication use at discharge nor associated with medication use at month 6. We found severity of PSF to be increased in patients with polypharmacy. Our results suggest that PSF is not a side effect of drugs use, which more reflects presence of disturbances frequently observed after stroke such as depression, anxiety, or sleep disturbances. Clinical study is registered on clinicaltrials.gov (NCT01330160).

Identifiers

PMID27413577
PMCPMC4930814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.